On-Demand Catalog

All sessions average between 60 and 90 minutes.

Development of Medical Devices: Best Practices for Safeguarding Your IP and FDA Rights
FDA, USDA, and EPA: Inter-Agency Overlap and Jurisdictional Boundaries
PDUFA and BsUFA Reauthorization: Key Changes Affecting Industry and Patients
Regulation of Cannabis in FDA-Regulated Products
The EU’s New Medical Device and IVD Regulations
REMS: Key Issues and Best Practices
Compounding Still in the Mix: Title I of the DQSA, the Compounding Quality Act, Three Years Later
False Claims Act Enforcement
Recent FDA Guidance Documents on Manufacturer Communications about Medical Products
21st Century Cures Act

Filter Results